BN.com Gift Guide

Health Economics of Dementia / Edition 1

Hardcover (Print)
Buy New
Buy New from BN.com
$464.55
Used and New from Other Sellers
Used and New from Other Sellers
from $165.54
Usually ships in 1-2 business days
(Save 70%)
Other sellers (Hardcover)
  • All (8) from $165.54   
  • New (6) from $322.04   
  • Used (2) from $165.54   

Overview

Drugs are being developed to alleviate the symptoms of dementia and different models of care are being tried. This book is a reference work in the subject. It gives a basis of the disease, its epidemiology, care implications, development and use of drugs. It discusses the challenges of obtaining reliable data and reviews the tools used to assess the costs of dementia to date. It also deals with the pharmacoeconomics of dementia.

Read More Show Less

Editorial Reviews

From the Publisher
"...to the best of my knowledge, this is the only comprehensive review on the health economics of dementia. The book shsould appeal to anyone with a special intrest in dementia, particulalry those involved in clinical trials..." (International Journal of Geriatric Psychiatry, Volume 14)
Booknews
With the topic still in its infancy, the focus of this book through its 38 contributions is methodological. It provides an introduction to the disease, its epidemiology, care implications, and the development and use of drugs. A sample of topics: different ways of organizing and financing health care, principles of pharmacoeconomics, costs of diagnostic procedures, severity scales, instruments to measure the family caregiver burden, drug authorities' policy on the assessment of drugs f or dementia, and a proposed health economics research agenda for dementia. Annotation c. by Book News, Inc., Portland, Or.
Read More Show Less

Product Details

  • ISBN-13: 9780471983767
  • Publisher: Wiley
  • Publication date: 10/23/1998
  • Edition number: 1
  • Pages: 596
  • Product dimensions: 6.26 (w) x 9.78 (h) x 1.47 (d)

Table of Contents

GENERAL ASPECTS.

Classification and Diagnostics (L. Fratiglioni).

Epidemiology (L. Fratiglioni).

Symptomatology: Functional Capacity and Behaviour (H. Brodaty D. Lie).

Care Options and Service Innovations in Dementia Care (L. Johansson).

Different Ways of Organizing and Financing Health Care (S. H嫡nsson).

Cultural Concepts of Care for the Demented (B. Ineichen).

Interaction with People Suffering Severe Dementia (A. Norberg).

Distress and Burden for Family Caregivers (C. Whitlatch).

HEALTH ECONOMICS APPROACHES TO DEMENTIA.

Principles of Pharmacoeconomics (M. Drummond).

Methodological Issues in Health Economic Studies of Dementia (G. Karlsson, et al.).

Modeling Disease Progression with Markov Models (F. Sonnenberg E. Leventhal).

Cost of Illness of Dementia (W. Max).

Costs of Dementia in the Netherlands (M. Koopmanschap, et al.).

Cost of Treatment and Care of Alzheimer's Disease in Germany (J.-M. Schulenburg, et al.).

Costing Community Care of People with Dementia (M. Knapp R. Wigglesworth).

Indirect Costs and Costing Informal Care (M. Koopmanschap W. Brouwer).

The Resident Assessment Instrument (RAI) and Resource Use in Dementia Care (G. Ljunggren J. Morris).

Costs of Diagnostic Procedures (S. Gauthier).

How Will Japan Cope with the Impending Surge of Dementia? (Y. Arai N. Ikegami).

Drug Costs in Dementia Care (J. Fastbom M. Giron).

Costs of Dementia-Specific Care Approaches (A. Wimo, et al.).

OUTCOME MEASUREMENTS.

Test Scores in Clinical Trials vs Performance in Real Life: Can Clinical Global Assessments Bridge the Gap? (R. Doody).

Severity Scales (B. Reisberg, et al.).

Measuring QALYs in Dementia (P. Neumann, et al.).

Assessing ADL/IADL in Persons with Dementia (L. Nyg岤).

Assessment of Cognitive Functioning (O. Almkvist).

Measurements of Quality of Life in Dementia (P. Whitehouse).

Assessment of Behavioral and Psychiatric Symptoms in Patients with Dementia Disorders (S. Eriksson A. Wimo).

Instruments to Measure the Family Caregiver Burden (M. Grafstr?. Sandman).

PHARMACOECONOMIC ASPECTS.

Drug Authorities' Policy on the Assessment of Drugs for Dementia (S. Hill P. McGettigan).

Designing Phase III Trials of Anti-dementia Drugs with a View Towards Pharmacoeconomic Considerations (L. Schneider).

Evaluation of the Healthcare Resource Utilization and Caregiver Time in Anti-dementia Drug Trials (A. Wimo, et al.).

Clinical and Economic Considerations of Anti-Dementia Drug Treatment: Efficacy, Effectiveness, Efficiency (H. Feldman B. Prigent).

Ethical Considerations in Pharmacoeconomic Trials in Dementia (S. Post).

Issues in Cross-Cultural Assessment of Economic Outcomes in Dementia (E. Witthaus).

Nursing Home Placement and Mortality as Outcomes in Clinical Trials of Anti-Dementia Drugs: Methodological Issues (S. Gracon F. Smith).

Outcomes Research and Alzheimer's Disease: A Pharmaceutical Industry Perspective (V. Mastey).

FINAL REMARKS.

A Proposed Health Economics Research Agenda for Dementia (B. Winblad, et al.).

Index. 

Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)